Chemical-structure (Chemical Structure)
Topiramate
Product Images NDC 50436-9952
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50436-9952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Figure 1)
This is a graph titled "Kaplan-Meier Estimates of Cumulative Rates for Time to First Seizure". The graph compares the effects of two doses of Topiramate (50mg/day and 400mg/day) on patients who are at risk of developing seizures. The X-axis represents the time in days, while the Y-axis represents the percentage of patients who have not had a seizure at a given time. The graph shows that patients who took 400mg/day of Topiramate had a significantly lower risk of experiencing a seizure compared to those who took 50mg/day. The statistical significance of the results is indicated by the p-value of 0.0002.*
Label Image (Lbl504369952)
This appears to be a label for a medication called Topiramate, with 200 mg pills and 60 tablets per bottle. NDC (National Drug Code) number 50436-9952-2 is also provided. It also mentions an ADC (Automated Dispensing Cabinet) number 62756-0712-13, which most likely refers to its inventory management system. The rest of the text is not legible.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
